Literature DB >> 11098932

Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.

B Seliger1, U Wollscheid, F Momburg, T Blankenstein, C Huber.   

Abstract

In murine tumor cell lines, downregulation of MHC class I surface expression has been frequently detected, but the underlying molecular mechanisms of such deficiencies have not been defined. In this study, murine tumor cell lines of different histology derived from spontaneous or from chemical-induced tumors were analyzed for the expression of multiple components of the major histocompatibility complex (MHC) class I antigen-processing machinery (APM), including the peptide transporter TAP, the interferon (IFN)-gamma inducible proteasome subunits and several chaperones. The tumor cell lines analyzed demonstrated a heterogeneous expression pattern of various APM components. In comparison to control cells an impaired coordinated expression of at least three APM components was detected. In particular, extensive APM deficiencies were found in cell lines derived from chemical-induced tumors. A strong coordinated downregulation of expression and/or function of TAP, the low molecular weight proteins (LMP) subunits, the proteasome activator PA28 and/or tapasin was found in 5 of 10 tumor cells, which was associated with impaired MHC class I surface expression. In contrast, the expression of beta2-microglobulin (beta2-m), PA28beta, the constitutive proteasome subunits X, Y, Z and of the chaperones calnexin, calreticulin, ER60 and phospho disulfide isomerase (PDI) was unaltered or only weakly decreased. The deficient expression of APM components could be corrected by IFN-gamma treatment, which also reconstituted MHC class I surface expression. However, impaired expression of APM molecules appears not to be the only cause of abnormal MHC class I expression, since it could neither be corrected by the addition of exogeneous MHC class I binding peptides nor by incubation at low temperature. These results suggest that one major mechanism of murine tumor cells, in particular chemical-induced tumors, to evade the immune system is the combined dysregulation of various APM components and other factors, which still have to be identified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098932     DOI: 10.1034/j.1399-0039.2000.560404.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.

Authors:  Sylvia Heink; Daniela Ludwig; Peter-M Kloetzel; Elke Krüger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-08       Impact factor: 11.205

2.  Cloning and functional analyses of the mouse tapasin promoter.

Authors:  Felix Herrmann; John Trowsdale; Christoph Huber; Barbara Seliger
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

Review 3.  Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Authors:  Annie A Wu; Virginia Drake; Huai-Shiuan Huang; ShihChi Chiu; Lei Zheng
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

Review 4.  MHC heterogeneity and response of metastases to immunotherapy.

Authors:  Ignacio Algarra; Federico Garrido; Angel M Garcia-Lora
Journal:  Cancer Metastasis Rev       Date:  2021-04-15       Impact factor: 9.264

5.  Epigenetic control of the immune escape mechanisms in malignant carcinomas.

Authors:  A Francesca Setiadi; Muriel D David; Robyn P Seipp; Jennifer A Hartikainen; Rayshad Gopaul; Wilfred A Jefferies
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

6.  Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer.

Authors:  Fulvia Cerruti; Marina Martano; Claudio Petterino; Enrico Bollo; Emanuela Morello; Renato Bruno; Paolo Buracco; Paolo Cascio
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

7.  Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.

Authors:  Shannon Murray; Andreas Lundqvist
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

8.  Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.

Authors:  A Nazmul H Khan; Christopher J Gregorie; Thomas B Tomasi
Journal:  Cancer Immunol Immunother       Date:  2007-11-28       Impact factor: 6.968

9.  Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.

Authors:  Veronika Vlková; Ivan Štěpánek; Veronika Hrušková; Filip Šenigl; Veronika Mayerová; Martin Šrámek; Jana Šímová; Jana Bieblová; Marie Indrová; Tomáš Hejhal; Nicolas Dérian; David Klatzmann; Adrien Six; Milan Reiniš
Journal:  Oncotarget       Date:  2014-08-30

10.  Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS).

Authors:  Frédéric Ebstein; Martin Keller; Annette Paschen; Peter Walden; Michael Seeger; Elke Bürger; Elke Krüger; Dirk Schadendorf; Peter-M Kloetzel; Ulrike Seifert
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.